Trial · NCT02782104
Adverse events476
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 476
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vertigo | Ear and labyrinth disorders | Esketamine Nasal Spray (IND Phase) | 77 | 458 | |
| other | Vertigo | Ear and labyrinth disorders | Esketamine Nasal Spray (OP/MA Phase) | 198 | 1,110 | |
| other | Diplopia | Eye disorders | Esketamine Nasal Spray (IND Phase) | 15 | 458 | |
| other | Diplopia | Eye disorders | Esketamine Nasal Spray (OP/MA Phase) | 58 | 1,110 | |
| other | Vision Blurred | Eye disorders | Esketamine Nasal Spray (IND Phase) | 35 | 458 | |
| other | Vision Blurred | Eye disorders | Esketamine Nasal Spray (OP/MA Phase) | 116 | 1,110 | |
| other | Abdominal Pain | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 4 | 458 | |
| other | Abdominal Pain | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 70 | 1,110 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 6 | 458 | |
| other | Abdominal Pain Upper | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 80 | 1,110 | |
| other | Constipation | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 6 | 458 | |
| other | Constipation | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 59 | 1,110 | |
| other | Diarrhoea | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 12 | 458 | |
| other | Diarrhoea | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 184 | 1,110 | |
| other | Hypoaesthesia Oral | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 38 | 458 | |
| other | Hypoaesthesia Oral | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 83 | 1,110 | |
| other | Nausea | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 82 | 458 | |
| other | Nausea | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 356 | 1,110 | |
| other | Paraesthesia Oral | Gastrointestinal disorders | Esketamine Nasal Spray (IND Phase) | 26 | 458 | |
| other | Paraesthesia Oral | Gastrointestinal disorders | Esketamine Nasal Spray (OP/MA Phase) | 69 | 1,110 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02782104/events